TABLE 1.
Strain | Source (reference) | Presence of capsule gene as determined by PCR assay
|
|||
---|---|---|---|---|---|
capABCDSh | capEFGSh | capHIJSh | capKLMSh | ||
JCSC1435 | Clinical isolate from Japan (25) | + | + | + | + |
8HT4 | JCSC1435 mutant with a 91.9-kb chromosomal deletion (25) | ||||
NRS9a | Peritoneal fluid | − | − | − | − |
NRS50 | Wound/skin/soft tissue | + | + | + | + |
NRS62 | Dialysis fluid | − | − | − | − |
NRS69 | Bloodstream | + | + | + | + |
NRS115 | Wound/skin/soft tissue | + | + | + | + |
NRS116 | Wound/skin/soft tissue | + | + | +b | +b |
M176 | Peritoneal fluid (3) | − | − | − | − |
8005-3 | Bovine strain from Norway (26) | − | − | − | − |
8622-1 | Bovine strain from Norway (26) | − | − | − | − |
8690-3 | Bovine strain from Norway (26) | − | − | − | − |
8733-3 | Bovine strain from Norway (26) | − | − | − | − |
8785-4 | Bovine strain from Norway (26) | − | − | − | − |
8690-3 | Bovine strain from Norway (26) | − | − | − | − |
NRS strains were clinical isolates from the United States that were obtained from the Network on Antimicrobial Resistance in Staphylococcus aureus.
Unlike the other clinical isolates that carried the capSh genes, strain NRS116 showed negative RT-PCRs with primers derived from capHISh and capKLSh (see text).